Today news
About the same in other media
FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds
Reading now: 978
wsj.comThe Food and Drug Administration could authorize Covid-19 boosters from Pfizer Inc. and BioNTech SE for use in 16- and 17-year olds as soon as next week as concerns rise over the possible spread of a new, possibly more transmissible variant, according to a person familiar with the planning.
The agency is planning to move rapidly to take action on a request by the companies to authorize boosters for 16- and-17 year olds, according to a person familiar with the matter. So far, only people 18 years and older are eligible for boosters.
Read more on wsj.comAbout this in other media
Universities including Berkeley, MIT, Harvard, Oxford to form EduDAO to promote Web 3 innovations, financed by BitDAO treasury cointelegraph.com /2 years ago
Texas oil company charged in massive spill off southern California coast theguardian.com /2 years ago
A 26-year-old short-seller on the Reddit retail army and shorting in the longest bull market in history fnlondon.com /2 years ago
Show more
The website finance-news.co. is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
